Prof. dr. Miriam Koopman (1975) received her MD (cum laude) at the Radboud University Medical Center, Nijmegen, NL, and was trained as a medical oncologist at the University Medical Center Utrecht, NL. She was a trainee at the Dana Farber Cancer Institute, Boston USA in 2008. She received her PhD (cum laude) in 2009 on her thesis “Towards an optimal use of chemotherapy in advanced colorectal cancer (CRC) patients”. Since 2010 she has a tenured staff position at the department of Medical Oncology at the University Medical Center Utrecht, NL. In 2017 she was appointed as Professor of Medical Oncology, with focus on CRC. Her main focus of clinical/translational research concerns the improvement of the prognosis of CRC patients by optimizing treatment and developing prognostic/predictive (bio)markers, with the main objective of personalized care for CRC patients. In order to achieve this, she employs two strategies: 1) the conduct of prospective clinical studies, which focused on clinically relevant questions and which provided a spin-off with a wealth of clinical/translational research data, and 2) collecting real-life data, which reflect the true value of novel developments, give insight in the quality of care, and serve as a rich source for a variety of research that benefit a great diversity of stakeholders. She is the founder and current chair of the Dutch Prospective CRC cohort study (PLCRC), to which currently the majority of Dutch hospitals participate and which contains data from >12.000 patients. Since 2019 she is (vice) chair of the Dutch Colorectal Cancer Group (DCCG).
Prof. Miriam Koopman is ESMO faculty member for the Gastro-Intestinal Tumours –colorectal since 2017 and is chair of the ESMO working group on Real World Data.
Mrch 2017 - Professor Medical Oncology, in particular colorectal cancer
Febr 2017 - Selected as Supervisor (promotor) of the Year 2017 in the Graduate School of Life Sciences Utrecht
December 2011 - Selected for program for talented female researchers, UMC Utrecht (Steyn Parvé program).
08-10-2010 - Best Poster Award: “Incidence and prognostic value of BRAF mutation in metastatic colorectal cancer (CRC) with mismatch repair deficiency (dMMR)”, ESMO Congress, Milan, Italy.
13-11-2009 - PhD thesis, cum laude: “Towards an optimal use of chemotherapy in advanced colorectal cancer patients”.
25-04-2008 - Best Clinical Research Paper 2007: Annual Meeting of the Nederlandse Internisten Vereniging (NIV), Maastricht: “Sequential versus combination chemotherapy with capecitabine, irinotecan, and oxaliplatin in advanced colorectal cancer, a Dutch Colorectal Cancer Group (DCCG) phase III study. Lancet 2007;370:135-42.
06-12-2007 - Dr. I.B.M. Frye Stipendium - Individual research grant for young outstanding female researchers to conduct an international research project, Radboud University Nijmegen, the Netherlands.
June 2007 - Selected as participant for the FECS-AACR-ASCO Workshop " Methods in clinical cancer research" Flims, Switzerland.
June 2006 - Annual award for the best resident of Internal Medicine. Radboud University Nijmegen Medical Centre.
30-06-2000 - MD cum laude.
Updated: March 2022